# Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects

> **NCT01794364** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06291874
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01794364
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2013-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01794364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01794364, "Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01794364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*